AstraZeneca PLC (AZN) Latest Stock News & Headlines - Yahoo …

Get the latest AstraZeneca PLC (AZN) stock news and headlines to help you in your trading and investing decisions.

09%
OFF

AstraZeneca PLC (AZN) Latest Stock News & Headlines - Yahoo …

2 weeks from now

The latest trading day saw Astrazeneca (AZN) settling at $66.58, representing a -0.09% change from its previous close. We recently compiled a list of the 10 Best FTSE Dividend Stocks To …

yahoo.com

09%
OFF

Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors …

2 weeks from now

2 days ago · In the latest trading session, Astrazeneca (AZN) closed at $66.58, marking a -0.09% move from the previous day. The stock's performance was behind the S&P 500's daily gain of …

yahoo.com

$0.25
OFF

Astrazeneca News Headlines. AZN Share News. Financial News …

2 weeks from now

Astrazeneca News Headlines. AZN Share News. Financial News Articles for Astrazeneca Plc Ord Shs $0.25 updated throughout the day.

lse.co.uk

$0.25
OFF

Astrazeneca Plc (AZN) News Headlines - ADVFN

2 weeks from now

Dec 11, 2024 · Get the latest up-to-the minute news on Astrazeneca from ADVFN. ADVFN ... Astrazeneca Plc: LSE:AZN: London: Ordinary Share: GB0009895292: ORD SHS $0.25 Price …

advfn.com

3%
OFF

Why Astrazeneca (AZN) Is A Top Growth Stock For The Long-Term

2 weeks from now

2 days ago · AZN also boasts an average earnings surprise of 3.3%. Looking at cash flow, Astrazeneca is expected to report cash flow growth of 6% this year; AZN has generated cash …

yahoo.com

4%
OFF

Deadline Alert: AstraZeneca PLC (AZN) Investors Who ... - Business …

2 weeks from now

3 days ago · On this news, AstraZeneca’s stock price fell $4.07, or 5.4%, over two consecutive trading days to close at $71.15 per share on November 1, 2024, thereby injuring investors.

businesswire.com

09%
OFF

Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors …

2 weeks from now

3 days ago · In the latest trading session, Astrazeneca (AZN Quick Quote AZN - Free Report) closed at $66.58, marking a -0.09% move from the previous day. The stock's performance …

zacks.com

4%
OFF

INVESTOR ALERT: Law Offices Of Howard G. Smith ... - Business Wire

2 weeks from now

Jan 2, 2025 · On this news, AstraZeneca’s stock price fell $4.07, or 5.4%, over two consecutive trading days to close at $71.15 per share on November 1, 2024, thereby injuring investors.

businesswire.com

FAQs about AstraZeneca PLC (AZN) Latest Stock News & Headlines - Yahoo … Coupon?

Who owns AstraZeneca (AZN) stock?

Only 0.04% of the stock of AstraZeneca is held by insiders. 51.03% of the stock of AstraZeneca is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Read more about AstraZeneca's insider trading history. Receive AZN Stock News and Ratings via Email ...

Is AstraZeneca (azn) a good buy right now?

Astrazeneca is holding a Zacks Rank of #3 (Hold) right now. In the context of valuation, Astrazeneca is at present trading with a Forward P/E ratio of 14.19. This valuation marks a premium compared to its industry's average Forward P/E of 12.67. It's also important to note that AZN currently trades at a PEG ratio of 1.04. ...

Did AstraZeneca mislead investors?

The Allegations: Robbins LLP is Investigating Allegations that AstraZeneca PLC (AZN) Misled Investors Regarding its Legal Exposure in China ...

Is AstraZeneca making news in China?

U.K.-based pharmaceutical giant AstraZeneca (NASDAQ: AZN) is making news, but not in a good way. Its operations in China were recently rocked when Leon Wang, the company's president in the country -- as well as several other top executives -- were arrested following fraud-related investigations by the authorities. ...

Is AstraZeneca a good stock to buy?

The the stock of pharmaceutical has fallen by 0.8% in the past month, leading the Medical sector's loss of 5.77% and the S&P 500's loss of 2.8%. Investors will be eagerly watching for the performance of Astrazeneca in its upcoming earnings disclosure. ...

Did AstraZeneca ads price fall again?

On this news, the price of AstraZeneca ADSs fell again, the complaint alleges. Finally, the AstraZeneca class action lawsuit alleges that on December 18, 2024, Financial Times published an article entitled "AstraZeneca insiders expect sales dip in China after arrest of local boss." ...